Anavex Life Sciences Stock Crushed As European Alzheimer’s Drug Filing Pulled After EMA Pushback

All NewsMarch 25, 2026

Anavex shares fall after pulling EU filing for blarcamesine in Alzheimer’s; EMA feedback prompts more data work.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent